Q4 2025 Prestige Consumer Healthcare Inc Earnings Call Transcript
Key Points
- Prestige Consumer Healthcare Inc (PBH) achieved record fiscal 2025 results with solid revenue and earnings growth, driven by a diversified portfolio of brands.
- Net revenue exceeded $1.1 billion, marking a 1% increase compared to the previous year, consistent with forecasts.
- The international segment experienced growth exceeding 5%, with strong performance in the North American GI brands such as Dramamine and Fleet.
- Adjusted EPS increased by approximately 7% to $4.52, aligning with long-term growth objectives.
- The company generated over $240 million in free cash flow, reducing leverage to 2.4 times while executing value-enhancing capital deployment.
- The business environment remains uncertain due to evolving tariffs, supply chain constraints, and inflation, which could impact future results.
- The Clear Eyes brand faced supply challenges, impacting its performance, although efforts are underway to address these issues.
- The cough and cold sales segment experienced declines, affecting overall performance in North America.
- Tariff impacts are anticipated to cost approximately $15 million in fiscal 2026, posing a challenge to cost management.
- The macroeconomic environment is fluid, with consumer uncertainty potentially affecting marketing and innovation strategies.
Good day and thank you for standing by, Welcome to the Prestige Consumer Healthcare's fourth quarter 2025, earnings conference call.
(Operator Instructions).
I would now like to hand the conference over to your speaker today, Phil Terpolilli, Vice President, Investor Relations and treasury, please go ahead.
Thanks, operator, and thank you to everyone who has joined today. On the call with me are Ron Lombardi, our Chairman, President and CEO, and Christine Sacco, our CFO and COO.
On today's call, we review our full year fiscal 2025, results, discuss our full year outlook, and then take questions from analysts.
A slide presentation accompanies today's call. It can be accessed by visiting prestige Consumerhealthcare.com, clicking on the investors link, and then on today's webcast and presentation.
Remember, some of the information contained in the presentation today includes Non-GAAP financial measures.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
